Animesh D Pardanani, MBBS, PhD

  • 19491 Citations
  • 77 Scopus h-Index
1993 …2020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1993 2020

Filter
Letter
2019
1 Citation (Scopus)

A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy

Gangat, N., Phelps, A., Lasho, T. L., Finke, C. M., Vallapureddy, R., Hanson, C. A., Ketterling, R. P., Patnaik, M. M., Pardanani, A. D. & Tefferi, A., Feb 1 2019, In : Blood Cancer Journal. 9, 2, 11.

Research output: Contribution to journalLetter

Thiamine
Neoplasms
Therapeutics
5 Citations (Scopus)

Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation

Patnaik, M. M., Pophali, P. A., Lasho, T. L., Finke, C. M., Horna, P., Ketterling, R. P., Gangat, N., Mangaonkar, A. A., Pardanani, A. D. & Tefferi, A., Jun 1 2019, In : Haematologica. 104, 6, p. e236-e239

Research output: Contribution to journalLetter

Open Access
Leukemia, Myelomonocytic, Chronic
Mutation
Survival

Cytogenetic clonal evolution in myeloproliferative neoplasms: contexts and prognostic impact among 648 patients with serial bone marrow biopsies

Tefferi, A., Nicolosi, M., Penna, D., Vallapureddy, R., Hanson, C. A., Pardanani, A. D., Gangat, N. & Ketterling, R. P., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalLetter

Clonal Evolution
Cytogenetics
Bone Marrow
Biopsy
Neoplasms

Functional evaluation of isocitrate dehydrogenase 1 and 2 variants of unclear significance in chronic myeloid neoplasms

Tischer, A., Antelo, G., Coltro, G., Finke, C. M., Gonsalves, W., Pardanani, A., Ketterling, R., Mangaonkar, A., Gangat, N., Tefferi, A., Patnaik, M. M. & Lasho, T. L., Dec 2019, In : Leukemia Research. 87, 106264.

Research output: Contribution to journalLetter

Isocitrate Dehydrogenase
Neoplasms
Open Access
Thrombocytosis
Myelodysplastic Syndromes
Neoplasms

Phenotypic heterogeneity associated with germline GATA2 haploinsufficiency: a comprehensive kindred study

Haddox, C. L., Carr, R. M., Abraham, R. S., Perez Botero, J., Rodriguez, V., Pardanani, A. D. & Patnaik, M. M., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

Haploinsufficiency
1 Citation (Scopus)

World Health Organization class-independent risk categorization in mastocytosis

Pardanani, A. D., Lasho, T. L., Reichard, K. K., Hanson, C. A. & Tefferi, A., Mar 1 2019, In : Blood cancer journal. 9, 3, 29.

Research output: Contribution to journalLetter

Open Access
Mastocytosis
2018

A retrospective survey of exposure history to chemotherapy or radiotherapy in 940 consecutive patients with primary myelofibrosis

Nicolosi, M., Mudireddy, M., Patnaik, M. M., Gangat, N., Pardanani, A. D. & Tefferi, A., Apr 1 2018, In : American Journal of Hematology. 93, 4, p. E103-E107

Research output: Contribution to journalLetter

Primary Myelofibrosis
Radiotherapy
History
Drug Therapy
Surveys and Questionnaires
3 Citations (Scopus)

Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms

Patnaik, M. M., Lasho, T., Howard, M., Finke, C., Ketterling, R. L., Al-Kali, A., Pardanani, A. D., Droin, N., Gangat, N., Tefferi, A. & Solary, E., Sep 1 2018, In : Blood Cancer Journal. 8, 9, 82.

Research output: Contribution to journalLetter

Leukemia, Myelomonocytic, Chronic
Retinoblastoma Genes
Dendritic Cells
Neoplasms
2 Citations (Scopus)

CSF3R-mutated chronic neutrophilic leukemia: Long-term outcome in 19 consecutive patients and risk model for survival

Szuber, N., Finke, C. M., Lasho, T. L., Elliott, M. A., Hanson, C. A., Pardanani, A. D. & Tefferi, A., Feb 1 2018, In : Blood Cancer Journal. 8, 2, 21.

Research output: Contribution to journalLetter

Leukemia, Neutrophilic, Chronic
Survival
5 Citations (Scopus)

Cytogenetic findings in WHO-defined polycythaemia vera and their prognostic relevance

Barraco, D., Cerquozzi, S., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Aug 1 2018, In : British Journal of Haematology. 182, 3, p. 437-440 4 p.

Research output: Contribution to journalLetter

Polycythemia Vera
Cytogenetics

Genetic predictors of response to specific drugs in primary myelofibrosis

Penna, D., Szuber, N., Lasho, T. L., Finke, C. M., Vallapureddy, R. R., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Nov 19 2018, In : Blood Cancer Journal. 8, 12, 1 p.

Research output: Contribution to journalLetter

Primary Myelofibrosis
Pharmaceutical Preparations
2 Citations (Scopus)

JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease

Tefferi, A., Lavu, S., Mudireddy, M., Lasho, T. L., Finke, C. M., Gangat, N., Pardanani, A. D., Hanson, C. A., Mannarelli, C., Guglielmelli, P. & Vannucchi, A. M., Apr 1 2018, In : American Journal of Hematology. 93, 4, p. E93-E96

Research output: Contribution to journalLetter

Polycythemia Vera
Exons
4 Citations (Scopus)

Long-term efficacy and safety of momelotinib, a JAK1 and JAK2 inhibitor, for the treatment of myelofibrosis

Pardanani, A. D., Gotlib, J., Roberts, A. W., Wadleigh, M., Sirhan, S., Kawashima, J., Maltzman, J. A., Shao, L., Gupta, V. & Tefferi, A., Apr 1 2018, In : Leukemia. 32, 4, p. 1034-1037 4 p.

Research output: Contribution to journalLetter

Primary Myelofibrosis
Safety
N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide
29 Citations (Scopus)

MIPSS701 version 2.0: Mutation and karyotype-enhanced international prognostic scoring system for primary myelofibrosis

Tefferi, A., Guglielmelli, P., Lasho, T. L., Gangat, N., Ketterling, R. P., Pardanani, A. D. & Vannucchi, A. M., Jun 10 2018, In : Journal of Clinical Oncology. 36, 17, p. 1769-1770 2 p.

Research output: Contribution to journalLetter

Primary Myelofibrosis
Karyotype
Mutation
9 Citations (Scopus)

Monocytosis is a powerful and independent predictor of inferior survival in primary myelofibrosis

Tefferi, A., Shah, S., Mudireddy, M., Lasho, T. L., Barraco, D., Hanson, C. A., Ketterling, R. P., Elliott, M. A., Patnaik, M. M., Pardanani, A. D. & Gangat, N., Dec 1 2018, In : British Journal of Haematology. 183, 5, p. 835-838 4 p.

Research output: Contribution to journalLetter

Primary Myelofibrosis
Monocytes
2 Citations (Scopus)

MPL-mutated essential thrombocythemia: a morphologic reappraisal

Szuber, N., Hanson, C. A., Lasho, T. L., Finke, C., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Nov 20 2018, In : Blood Cancer Journal. 8, 12, 1 p.

Research output: Contribution to journalLetter

Essential Thrombocythemia

Normal karyotype in myelofibrosis: Is prognostic integrity affected by the number of metaphases analyzed?

Nicolosi, M., Mudireddy, M., Gangat, N., Pardanani, A. D., Hanson, C. A., Ketterling, R. P. & Tefferi, A., Jan 1 2018, In : Blood Cancer Journal. 8, 1, 8.

Research output: Contribution to journalLetter

Primary Myelofibrosis
Metaphase
Karyotype
3 Citations (Scopus)

Prognostic interaction between bone marrow morphology and SF3B1 and ASXL1 mutations in myelodysplastic syndromes with ring sideroblasts

Mangaonkar, A. A., Lasho, T. L., Finke, C. M., Gangat, N., Al-Kali, A., Elliott, M. A., Begna, K., Alkhateeb, H., Wolanskyj-Spinner, A. P., Hanson, C. A., Ketterling, R. P., Hogan, W., Pardanani, A. D., Litzow, M. R., Tefferi, A. & Patnaik, M. M., Feb 1 2018, In : Blood Cancer Journal. 8, 2, 18.

Research output: Contribution to journalLetter

Myelodysplastic Syndromes
Bone Marrow
Mutation
8 Citations (Scopus)

Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis

Tefferi, A., Lasho, T. L., Finke, C., Gangat, N., Hanson, C. A., Ketterling, R. P. & Pardanani, A. D., Mar 1 2018, In : Leukemia. 32, 3, p. 837-839 3 p.

Research output: Contribution to journalLetter

Primary Myelofibrosis
Alleles
Mutation
1 Citation (Scopus)

Serum erythropoietin levels in essential thrombocythemia: phenotypic and prognostic correlates

Szuber, N., Lavu, S., Mudireddy, M., Nicolosi, M., Penna, D., Vallapureddy, R. R., Lasho, T. L., Finke, C., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Nov 19 2018, In : Blood Cancer Journal. 8, 12, 1 p.

Research output: Contribution to journalLetter

Essential Thrombocythemia
Erythropoietin
Serum
2 Citations (Scopus)

Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis

Mudireddy, M., Gangat, N., Hanson, C. A., Ketterling, R. P., Pardanani, A. D. & Tefferi, A., Jun 1 2018, In : Blood Cancer Journal. 8, 6

Research output: Contribution to journalLetter

Primary Myelofibrosis
2017
9 Citations (Scopus)

Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis

Tefferi, A., Saeed, L., Hanson, C. A., Ketterling, R. P., Pardanani, A. D. & Gangat, N., Jan 1 2017, In : Leukemia. 31, 12, p. 2851-2852 2 p.

Research output: Contribution to journalLetter

Essential Thrombocythemia
Polycythemia Vera
Primary Myelofibrosis

Liver function test abnormalities and their clinical relevance in primary myelofibrosis

Barraco, D., Mudireddy, M., Shah, S., Hanson, C. A., Ketterling, R. P., Gangat, N., Pardanani, A. D. & Tefferi, A., Jan 1 2017, In : Blood Cancer Journal. 7, 4, e557.

Research output: Contribution to journalLetter

Primary Myelofibrosis
Liver Function Tests
3 Citations (Scopus)

Marked elevation of serum lactate dehydrogenase in primary myelofibrosis: Clinical and prognostic correlates

Shah, S., Mudireddy, M., Hanson, C. A., Ketterling, R. P., Gangat, N., Pardanani, A. D. & Tefferi, A., Dec 1 2017, In : Blood Cancer Journal. 7, 12, 657.

Research output: Contribution to journalLetter

Primary Myelofibrosis
L-Lactate Dehydrogenase
Serum
7 Citations (Scopus)

Mutations and karyotype in myelodysplastic syndromes: TP53 clusters with monosomal karyotype, RUNX1 with trisomy 21, and SF3B1 with inv(3)(q21q26.2) and del(11q)

Tefferi, A., Idossa, D., Lasho, T. L., Mudireddy, M., Finke, C., Shah, S., Nicolosi, M., Patnaik, M. M., Pardanani, A. D., Gangat, N., Hanson, C. A. & Ketterling, R. P., Dec 1 2017, In : Blood Cancer Journal. 7, 12, 658.

Research output: Contribution to journalLetter

Myelodysplastic Syndromes
Down Syndrome
Karyotype
Mutation
20 Citations (Scopus)

The effect of arterial hypertension on thrombosis in low-risk polycythemia vera

Barbui, T., Vannucchi, A. M., Carobbio, A., Rumi, E., Finazzi, G., Gisslinger, H., Ruggeri, M., Randi, M. L., Cazzola, M., Rambaldi, A., Gisslinger, B., Pieri, L., Thiele, J., Pardanani, A. D. & Tefferi, A., Jan 1 2017, In : American Journal of Hematology. 92, 1, p. E5-E6

Research output: Contribution to journalLetter

Polycythemia Vera
Thrombosis
Hypertension
2016
12 Citations (Scopus)

ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis

Pardanani, A. D., Lasho, T. L., Finke, C., Zblewski, D. L., Abdelrahman, R. A., Wassie, E. A., Gangat, N., Hanson, C. A., Ketterling, R. P. & Tefferi, A., Nov 1 2016, In : British Journal of Haematology. 175, 3, p. 534-536 3 p.

Research output: Contribution to journalLetter

Systemic Mastocytosis
Mutation
7 Citations (Scopus)

Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience

Begna, K., Abdelatif, A., Schwager, S., Hanson, C., Pardanani, A. D. & Tefferi, A., May 27 2016, In : Blood Cancer Journal. 6, p. e427

Research output: Contribution to journalLetter

Busulfan
Neoplasms
1 Citation (Scopus)

Leukocytosis and presence of CALR mutation is associated with non-hepatosplenic extramedullary hematopoiesis in primary myelofibrosis

Barraco, D., Lasho, T. L., Gangat, N., Finke, C., Elala, Y. C., Pardanani, A. D. & Tefferi, A., Jun 17 2016, In : Blood Cancer Journal. 6, p. e436

Research output: Contribution to journalLetter

Extramedullary Hematopoiesis
Primary Myelofibrosis
Leukocytosis
Mutation